Euthanasia.

av Illidge, T. M., Kirkham, S. R.
Publicerad 1992

The antitumor immune response generated by fractionated radiation therapy may be limited by tumor cell adaptive resistance and can be circumvented by PD-L1 blockade

av Dovedi, S J, Illidge, T M
I publikationen Oncoimmunology (2015)

The influence of radiation in the context of developing combination immunotherapies in cancer

av Honeychurch, Jamie, Illidge, Timothy M.
I publikationen Ther Adv Vaccines Immunother (2018)

Synchronous apoptosis in established tumors leads to the induction of adaptive immunity

av Honeychurch, Jamie, Dive, Caroline, Illidge, Timothy M.
Publicerad 2013

Radiotherapy–Immunotherapy Combination: How Will We Bridge the Gap Between Pre-Clinical Promise and Effective Clinical Delivery?

av Romano, Erminia, Honeychurch, Jamie, Illidge, Timothy M.
I publikationen Cancers (Basel) (2021)

Stereotactic ablative radiotherapy and immunotherapy combinations: turning the future into systemic therapy?

av Walshaw, Richard C, Honeychurch, Jamie, Illidge, Tim M
I publikationen Br J Radiol (2016)

Reprogramming the tumour microenvironment by radiotherapy: implications for radiotherapy and immunotherapy combinations

av Colton, Madyson, Cheadle, Eleanor J., Honeychurch, Jamie, Illidge, Tim M.
I publikationen Radiat Oncol (2020)

Radiotherapy physics research in the UK: challenges and proposed solutions

av Mackay, R I, Burnet, N G, Green, S, Illidge, T M, Staffurth, J N
Publicerad 2012

Upregulation of meiosis-specific genes in lymphoma cell lines following genotoxic insult and induction of mitotic catastrophe

av Kalejs, Martins, Ivanov, Andrey, Plakhins, Gregory, Cragg, Mark S, Emzinsh, Dzintars, Illidge, Timothy M, Erenpreisa, Jekaterina
Publicerad 2006

A TLR7 agonist enhances the antitumor efficacy of obinutuzumab in murine lymphoma models via NK cells and CD4 T cells

av Cheadle, E J, Lipowska-Bhalla, G, Dovedi, S J, Fagnano, E, Klein, C, Honeychurch, J, Illidge, T M
I publikationen Leukemia (2017)

Erratum: A TLR7 agonist enhances the antitumor efficacy of obinutuzumab in murine lymphoma models via NK cells and CD4 T cells

av Cheadle, E J, Lipowska-Bhalla, G, Dovedi, S J, Fagnano, E, Klein, C, Honeychurch, J, Illidge, T M
I publikationen Leukemia (2017)

Sustained tumour eradication after induced caspase-3 activation and synchronous tumour apoptosis requires an intact host immune response

av Melis, M H M, Simpson, K L, Dovedi, S J, Welman, A, MacFarlane, M, Dive, C, Honeychurch, J, Illidge, T M
Publicerad 2013

Antibody-induced nonapoptotic cell death in human lymphoma and leukemia cells is mediated through a novel reactive oxygen species-dependent pathway

av Honeychurch, Jamie, Alduaij, Waleed, Azizyan, Mahsa, Cheadle, Eleanor J., Pelicano, Helene, Ivanov, Andrei, Huang, Peng, Cragg, Mark S., Illidge, Tim M.
I publikationen Blood (2012)

Antitumor efficacy of radiation plus immunotherapy depends upon dendritic cell activation of effector CDS(+) T cells

av Dovedi, Simon J., Lipowska-Bhalla, Grazyna, Beers, Stephen A., Cheadle, Eleanor J., Mu, Lijun, Glennie, Martin J., Illidge, Timothy M., Honeychurch, Jamie
I publikationen Cancer Immunol Res (2016)

Akt inhibition improves long‐term tumour control following radiotherapy by altering the microenvironment

av Searle, Emma J, Telfer, Brian A, Mukherjee, Debayan, Forster, Duncan M, Davies, Barry R, Williams, Kaye J, Stratford, Ian J, Illidge, Tim M
I publikationen EMBO Mol Med (2017)

Endopolyploidy in irradiated p53-deficient tumour cell lines: Persistence of cell division activity in giant cells expressing Aurora B- kinase

av Erenpreisa, Jekaterina, Ivanov, Andrei, Wheatley, Sally P, Kosmacek, Elizabeth A, Ianzini, Fiorenza, Anisimov, Alim P, Mackey, Michael, Davis, Paul J, Plakhins, Grigorijs, Illidge, Timothy M
Publicerad 2008

Assessment of circulating biomarkers for potential pharmacodynamic utility in patients with lymphoma

av Greystoke, A, O'Connor, J P B, Linton, K, Taylor, M B, Cummings, J, Ward, T, Maders, F, Hughes, A, Ranson, M, Illidge, T M, Radford, J, Dive, C
Publicerad 2011

Novel type II anti-CD20 monoclonal antibody (GA101) evokes homotypic adhesion and actin-dependent, lysosome-mediated cell death in B-cell malignancies

av Alduaij, Waleed, Ivanov, Andrei, Honeychurch, Jamie, Cheadle, Eleanor J., Potluri, Sandeep, Lim, Sean H., Shimada, Kazuyuki, Chan, Claude H. T., Tutt, Alison, Beers, Stephen A., Glennie, Martin J., Cragg, Mark S., Illidge, Tim M.
Publicerad 2011

A novel systemically administered toll-like receptor 7 agonist potentiates the effect of ionizing radiation in murine solid tumor models

av Adlard, Amy L, Dovedi, Simon J, Telfer, Brian A, Koga-Yamakawa, Erina, Pollard, Charlotte, Honeychurch, Jamie, Illidge, Timothy M, Murata, Masashi, Robinson, David T, Jewsbury, Philip J, Wilkinson, Robert W, Stratford, Ian J
I publikationen Int J Cancer (2014)

Maximum tumor diameter is associated with event-free survival in PET-negative patients with stage I/IIA Hodgkin lymphoma

av Illidge, Tim M., Phillips, Elizabeth H., Counsell, Nicholas, Pettengell, Ruth, Johnson, Peter W. M., Culligan, Dominic J., Popova, Bilyana, Clifton-Hadley, Laura, McMillan, Andrew, Hoskin, Peter, Barrington, Sally F., Radford, John
I publikationen Blood Adv (2020)